The dissenting judge reviewed legislative history, federal and state, and concluded that statutory language and legislative history confirmed the director’s decision that he lacked authority to reschedule marijuana. She also pointed out that under the Controlled Dangerous Substances Therapeutic Research Act, N.J.S.A. 26:2L-12-9, the legislature intended to support research regarding the use of certain Schedule I controlled dangerous substances to alleviate certain medical problems.
